These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34929360)

  • 1. Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products.
    Díez JM; Romero C; Gajardo R
    Int J Infect Dis; 2022 Mar; 116():68-73. PubMed ID: 34929360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
    Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
    Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dominance of human coronavirus OC43 and NL63 infections in infants.
    Dijkman R; Jebbink MF; Gaunt E; Rossen JW; Templeton KE; Kuijpers TW; van der Hoek L
    J Clin Virol; 2012 Feb; 53(2):135-9. PubMed ID: 22188723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiology of human coronaviruses in three rural communities in Ghana.
    Owusu M; Sylverken AA; El-Duah P; Acheampong G; Mutocheluh M; Adu-Sarkodie Y
    Pan Afr Med J; 2021; 38():244. PubMed ID: 34104292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Culture Methods for Human Coronaviruses HCoV-OC43, HCoV-229E, and HCoV-NL63.
    Fausto A; Otter CJ; Bracci N; Weiss SR
    Curr Protoc; 2023 Oct; 3(10):e914. PubMed ID: 37882768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020.
    Faye MN; Barry MA; Jallow MM; Wade SF; Mendy MP; Sy S; Fall A; Kiori DE; Ndiaye NK; Goudiaby D; Diamanka A; Niang MN; Dia N
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
    Che XY; Qiu LW; Liao ZY; Wang YD; Wen K; Pan YX; Hao W; Mei YB; Cheng VC; Yuen KY
    J Infect Dis; 2005 Jun; 191(12):2033-7. PubMed ID: 15897988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus HKU1 and other coronavirus infections in Hong Kong.
    Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY
    J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.
    Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick LC
    BMC Infect Dis; 2024 Sep; 24(1):1042. PubMed ID: 39333882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity.
    Guzmán-Martínez O; Guardado K; Varela-Cardoso M; Trujillo-Rivera A; Gómez-Ñañez I; Ortiz-León MC; Espinosa R; Ramos C; Pérez-Carreón JI; López-Guerrero DV; Sampieri CL; Alanís-García AB; Rojas-Durán F; Zenteno-Cuevas R; Gutiérrez M; Montero H
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.